173 related articles for article (PubMed ID: 37738592)
41.
Stasiłowicz A; Tomala A; Podolak I; Cielecka-Piontek J
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466734
[No Abstract] [Full Text] [Related]
42. Role of cannabis in inflammatory bowel diseases.
Perisetti A; Rimu AH; Khan SA; Bansal P; Goyal H
Ann Gastroenterol; 2020; 33(2):134-144. PubMed ID: 32127734
[TBL] [Abstract][Full Text] [Related]
43. Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies.
Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
Psychopharmacology (Berl); 2022 May; 239(5):1211-1230. PubMed ID: 34613429
[TBL] [Abstract][Full Text] [Related]
44. Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey.
Neufeld T; Pfuhlmann K; Stock-Schröer B; Kairey L; Bauer N; Häuser W; Langhorst J
Z Gastroenterol; 2021 Oct; 59(10):1068-1077. PubMed ID: 34157755
[TBL] [Abstract][Full Text] [Related]
45. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
[TBL] [Abstract][Full Text] [Related]
46. The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes.
Modaresi F; Talachian K
Pharmaceut Med; 2022 Dec; 36(6):387-400. PubMed ID: 36357543
[TBL] [Abstract][Full Text] [Related]
47. Cannabinoids for skin diseases and hair regrowth.
Gupta AK; Talukder M
J Cosmet Dermatol; 2021 Sep; 20(9):2703-2711. PubMed ID: 34363728
[TBL] [Abstract][Full Text] [Related]
48. Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
Babson KA; Sottile J; Morabito D
Curr Psychiatry Rep; 2017 Apr; 19(4):23. PubMed ID: 28349316
[TBL] [Abstract][Full Text] [Related]
49. Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease.
Rotolo MC; Pellegrini M; Martucci P; Giacobbe R; De Palma A; Pacifici R; Pichini S; Busardò FP; Bisconti M
Clin Chem Lab Med; 2019 Mar; 57(4):498-503. PubMed ID: 30231009
[TBL] [Abstract][Full Text] [Related]
50. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon?
Grill M; Hasenoehrl C; Storr M; Schicho R
Med Cannabis Cannabinoids; 2018 Jun; 1(1):28-35. PubMed ID: 34676319
[TBL] [Abstract][Full Text] [Related]
51. Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users.
Taylor M; Lees R; Henderson G; Lingford-Hughes A; Macleod J; Sullivan J; Hickman M
Drug Alcohol Rev; 2017 Mar; 36(2):220-226. PubMed ID: 27296783
[TBL] [Abstract][Full Text] [Related]
52. Insights into the role of cannabis in the management of inflammatory bowel disease.
Picardo S; Kaplan GG; Sharkey KA; Seow CH
Therap Adv Gastroenterol; 2019; 12():1756284819870977. PubMed ID: 31523278
[TBL] [Abstract][Full Text] [Related]
53. Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
[No Abstract] [Full Text] [Related]
54. Alcohol and cannabis consumption in patients with inflammatory bowel disease: prevalence, pattern of consumption and impact on the disease.
Martinho-Grueber M; Kapoglou I; Bravo F; Sarraj R; Benz E; Restellini S; Biedermann L; Rogler G; Vavricka SR; Schoepfer A; Maillard MH; Michetti P; Brunner F; Clair C; Barry MP; Pittet V; von Känel R; Juillerat P
Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):21-30. PubMed ID: 36317770
[TBL] [Abstract][Full Text] [Related]
55. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
Botsford SL; Yang S; George TP
Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
[TBL] [Abstract][Full Text] [Related]
56. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
Baron EP
Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
[TBL] [Abstract][Full Text] [Related]
57. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease.
Bogale K; Raup-Konsavage W; Dalessio S; Vrana K; Coates MD
Med Cannabis Cannabinoids; 2021; 4(2):97-106. PubMed ID: 35224429
[TBL] [Abstract][Full Text] [Related]
58. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry.
Dalavaye N; Erridge S; Nicholas M; Pillai M; Bapir L; Holvey C; Coomber R; Rucker JJ; Hoare J; Sodergren MH
Expert Rev Gastroenterol Hepatol; 2023 Jan; 17(1):85-98. PubMed ID: 36562418
[TBL] [Abstract][Full Text] [Related]
59. [Cannabis and cannabinoids in palliative care].
Rasche T; Emmert D; Radbruch L; Conrad R; Mücke M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):830-835. PubMed ID: 31161228
[TBL] [Abstract][Full Text] [Related]
60. The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis.
Hammond S; Erridge S; Mangal N; Pacchetti B; Sodergren MH
Cannabis Cannabinoid Res; 2021 Dec; 6(6):474-487. PubMed ID: 34664988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
